Legal 500
Log in or register
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR
  • Rankings

    • Jurisdictions
    • Submissions
    • Future Lawyers
  • Firms & Lawyers

    • Service Providers
    • Barristers’ Sets
    • Networks
    • Interview with…
  • In-House

    • In-House Content
    • GC Powerlist
  • Knowledge Centre

    • Data Products
    • Legal Business
    • Market Intelligence
    • About us

      • Legal 500
      • FAQs
      • Marketing
      • Careers
      • Trust Centre
      • Contact us
  • Comparative Guides
  • Events
  • Legal 500 TV

About us

  • Legal 500
  • FAQs
  • Marketing
  • Careers
  • Trust Centre
  • Contact us
  • Deutschland DE
  • Paris FR

© 2026 Legalease Ltd. All rights reserved

Registered company in England & Wales No. 02427356 VAT GB 321 5727 22

Registered address: 188 Fleet Street, London, EC4A 2AG

  • Legal 500 Trust Centre
  • Contact Us
  • home
  • Market Intelligence
  • Search

14,474 results found

Use advanced search filters to refine your search

2 filters applied

Advanced search filters

Topics
Countries
Contributor

Start typing to add contributors

Content type
Show options
  • Article

    Pa. And NJ Adult Use—How's That Legalization Thing Coming Along?

    Both Pennsylvania and New Jersey have governors who have expressed an interest in legalizing cannabis for recreational
    United StatesFood, Drugs, Healthcare, Life Sciences
    Wilson Elser Moskowitz Edelman & Dicker LLP
    Wilson Elser Moskowitz Edelman & Dicker LLP
  • Article

    Passage Of American Rescue Plan Act Of 2021 Could Mean Larger Medicaid Drug Rebate Program Rebates For Pharmaceutical Manufacturers

    The American Rescue Plan Act of 2021, signed into law by President Biden on March 11, 2021, is a $1.9 trillion aid package that provides assistance to businesses and individuals experiencing financial hardship due to COVID-19.
    United StatesFood, Drugs, Healthcare, Life Sciences
ArentFox Schiff
ArentFox Schiff
  • Article

    Phacilitate Leaders/World Stem Cell Summit - Regenerative Medicine Enforcement Developments For Clinicians

    Barbara Binzak Blumenfeld presented at the Phacilitate Leaders/World Stem Cell Summit conference on January 22 in Miami. Her presentation, "Regenerative Medicine Enforcement...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Buchanan Ingersoll & Rooney
    Buchanan Ingersoll & Rooney
  • Article

    Plaintiff Stated Claim That "100% Natural" Deceives When GMOs Are Used

    The plaintiff alleged injury based on allegations that GMO-free oil is sold at a premium price.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    Polpharma And Tuteur Enter License For The Commercialization Of A Biosimilar Targeting Autoimmune Diseases In Latin America

    Explore the latest developments in biosimilar approvals, regulatory updates, and strategic acquisitions shaping the pharmaceutical landscape.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Article

    Preparing A Promising Drug Candidate For ANDA Litigation - Part 2

    If you read part one of this series, you appreciate that it is imperative that all individuals involved in drug development — including scientific, regulatory, marketing, and financial personnel...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
    Finnegan, Henderson, Farabow, Garrett & Dunner LLP
  • Article

    President Announces New Initiatives To Address Opioid Abuse

    The presidential memorandum instructs federal agencies to train their physician employees in proper prescribing practices, among other things.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    President Obama Nominates Robert Califf As FDA Commissioner

    On September 15, 2015, President Barack Obama announced the nomination of Robert Califf to be the next commissioner of the U.S. Food and Drug Administration, succeeding Stephen Ostroff...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    President Obama Signs Bipartisan FDA User Fee Legislation

    The U.S. Food and Drug Administration can assess user fees to support the agency's review of marketing applications for drugs, biologics and medical devices.
    United StatesFood, Drugs, Healthcare, Life Sciences
    McDermott Will & Emery
    McDermott Will & Emery
  • Article

    President Obama Signs Two Bipartisan Pharmaceutical Bills Into Law

    The White House recently announced that President Obama signed into law S. 2512 and S. 483, two pieces of pharmaceutical legislation that received bipartisan support in both the House and the Senate.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    President Signs Comprehensive Addiction And Recovery Act, Calls For Additional Funding

    In signing the bill, the President called on Congress to finish the job and provide adequate funding to deal with this public health crisis."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Reed Smith
    Reed Smith
  • Article

    President Signs Drug Quality And Security Act

    On November 27, 2013, President Obama signed the Drug Quality and Security Act, which amends the Food, Drug and Cosmetic Act. The
    United StatesFood, Drugs, Healthcare, Life Sciences
    Fox Rothschild LLP
    Fox Rothschild LLP
  • Article

    President Signs Federal GMO Legislation Into Law Preempting State Laws

    On July 29, 2016, President Obama signed into law S.764, the bill that creates the "National Bioengineered Food Disclosure Standard."
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Recent Product Recalls - Pharmaceutical & Medical Device Regulatory Update, Vol. II, Issue 4

    Injection drug products continued to be recalled for various issues.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Regulation And Legislation

    On Jan. 26, 2018, farms that sold an average of more than $500,000 in produce during each of the past three years were required to comply with the FDA Food Safety Modernization Act (FSMA).
    United StatesFood, Drugs, Healthcare, Life Sciences
    Holland & Knight
    Holland & Knight
  • Article

    Report Shows Most New Drugs Now Undergo Special Approval Process

    The 21st Century Cures legislation aims to add another special approval process for so-called dorman therapies.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Restaurant Liquor License Requirements Relaxed For Parts Of Downtown Orlando

    On March 23, 2018, Governor Rick Scott signed House Bill 1447 into law, paving the way for easier access to alcoholic beverage licenses for restaurants located in certain parts of downtown Orlando.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Lowndes
    Lowndes
  • Article

    Rudd Center Releases Report On Marketing Beverages To Children

    The University of Connecticut's Rudd Center for Food Policy & Obesity has released a report on the state of nutrition and marketing for beverages targeted to children.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Shook, Hardy & Bacon LLP
    Shook, Hardy & Bacon LLP
  • Article

    Rural Business-Cooperative Service Invites Applications For Value-Added Producer Grants

    In the May 15, 2015, Federal Register, the Rural Business-Cooperative Service published a correction of a previous notice of May 8, 2015...
    United StatesFood, Drugs, Healthcare, Life Sciences
    Jones Day
    Jones Day
  • Article

    Sandoz Invests In New Biosimilar Manufacturing Facility

    On July 20, 2023, Sandoz announced that it plans to invest approximately $90 million to build a Biosimilar Technical Development Center in Ljubljana, Slovenia by 2026.
    United StatesFood, Drugs, Healthcare, Life Sciences
    Goodwin Procter LLP
    Goodwin Procter LLP
  • Showing 801–820 of 14474 results

    PreviousNext
    Legal Intelligence Newsletters: sign up for the latest legal and regulatory news on your chosen topics